AfterRaise/Weekly/Week 2, 2026

The AfterRaise week

Week 2, 2026

55 rounds, $26.5B of announced capital. The largest: xAI raised $20.0B. Sorted by size; every figure links to its source.

MoveFundingObserved8 months ago

xAI

Series E · USA · Other

What happened

Raised $20.0B in Series E funding.

The company said the funding supports continue to accelerate infrastructure buildout, enable the rapid development and deployment of AI products reaching billions of users, and fuel research advancing xAI's core mission to understand the universe.

Likely next InferredNew market entryFirst local hires in the new marketLocal entity and legal setup

Where you helpInfrastructure and computeData partnershipsProduct leadershipMarket-entry advisersLocal employment infrastructure

Approach preferences not yet specified

Company room Source

MoveFundingObserved8 months ago

Global Technical Realty

Undisclosed · London, UK · AI & Data Infrastructure

What happened

Raised $1.9B.

The company said the funding supports expand operations and its development efforts.

Likely next InferredNew market entryFirst local hires in the new marketLocal entity and legal setup

Where you helpInfrastructure and computeSecurity reviewData partnershipsProduct leadershipMarket-entry advisers

Approach preferences not yet specified

Company room Source

MoveFundingObserved8 months ago

Kraken

Undisclosed · UK · Other

What happened

Raised $1.0B, led by D1 Capital Partners.

The announcement did not set out what the funding supports.

Likely next InferredAggressive multi-front expansionSenior executive hiringOperational scale

Where you helpCommercial leadershipOperations hiringGo-to-market partnershipsFinance and compliance

Approach preferences not yet specified

Company room Source

MoveFundingObserved8 months ago

Cyera

Series F · NYC, USA · AI & Data Infrastructure

What happened

Raised $400M in Series F funding.

The announcement did not set out what the funding supports.

Likely next InferredAggressive multi-front expansionSenior executive hiringOperational scale

Where you helpCommercial leadershipOperations hiringGo-to-market partnershipsFinance and compliance

Approach preferences not yet specified

Company room Source

MoveFundingObserved8 months ago

Erebor Bank

Undisclosed · Columbus, USA · Fintech & Insurance

What happened

Raised $350M, led by Lux Capital.

The announcement did not set out what the funding supports.

Likely next InferredAggressive multi-front expansionSenior executive hiringOperational scale

Where you helpCompliance and licensingRisk managementBanking partnershipsEnterprise salesFraud prevention

Approach preferences not yet specified

Company room Source

MoveFundingObserved8 months ago

Parabilis Medicines

Series F · Cambridge, USA · Biotech & Pharma

What happened

Raised $305M in Series F funding.

The announcement did not set out what the funding supports.

Likely next InferredResearch programme expansionScientific team growthAggressive multi-front expansion

Where you helpClinical operationsScientific hiringScientific advisersResearch operationsSpecialist suppliers

Approach preferences not yet specified

Company room Source

MoveFundingObserved8 months ago

Rain

Series C · NYC, USA · Fintech & Insurance

What happened

Raised $250M in Series C funding.

The announcement did not set out what the funding supports.

Likely next InferredPlatform and infrastructure scalingInfrastructure hiringAggressive multi-front expansion

Where you helpBanking partnershipsData securityPlatform engineeringCloud and compute partnersSecurity review

Approach preferences not yet specified

Company room Source

MoveFundingObserved8 months ago

Soley Therapeutics

Series C · San Francisco, USA · Biotech & Pharma

What happened

Raised $200M in Series C funding.

The announcement did not set out what the funding supports.

Likely next InferredResearch programme expansionScientific team growthAggressive multi-front expansion

Where you helpClinical operationsScientific hiringScientific advisersResearch operationsSpecialist suppliers

Approach preferences not yet specified

Company room Source

MoveFundingObserved8 months ago

Alveus Therapeutics

Series A · Philadelphia, USA · Biotech & Pharma

What happened

Raised $160M in Series A funding.

The announcement did not set out what the funding supports.

Likely next InferredResearch programme expansionScientific team growthAccelerated hiring across functions

Where you helpClinical operationsScientific hiringScientific advisersResearch operationsSpecialist suppliers

Approach preferences not yet specified

Company room Source

MoveFundingObserved8 months ago

LMArena

Series A · San Francisco, USA · AI & Data Infrastructure

What happened

Raised $150M in Series A funding, led by Felicis and UC Investments (University of California).

The company said the funding supports expand operations and its development efforts.

Likely next InferredNew market entryFirst local hires in the new marketLocal entity and legal setup

Where you helpInfrastructure and computeData partnershipsProduct leadershipMarket-entry advisersLocal employment infrastructure

Approach preferences not yet specified

Company room Source

MoveFundingObserved8 months ago

Diagonal Therapeutics

Series B · Watertown, USA · Biotech & Pharma

What happened

Raised $125M in Series B funding.

The announcement did not set out what the funding supports.

Likely next InferredRegulatory and certification milestonesCompliance team growthAggressive multi-front expansion

Where you helpRegulatory affairsQuality systemsScientific hiringRegulatory advisersCertification specialists

Approach preferences not yet specified

Company room Source

MoveFundingObserved8 months ago

Corgi

Undisclosed · San Francisco, USA · Fintech & Insurance

What happened

Raised $108M.

The announcement did not set out what the funding supports.

Likely next InferredProduct launches and new tiersProduct leadership hiringAggressive multi-front expansion

Where you helpBanking partnershipsProduct leadershipDesign partnersSpecialist engineeringCompliance and licensing

Approach preferences not yet specified

Company room Source

MoveFundingObserved8 months ago

EpiBiologics

Series B · San Mateo, USA · Biotech & Pharma

What happened

Raised $107M in Series B funding.

The announcement did not set out what the funding supports.

Likely next InferredAggressive multi-front expansionSenior executive hiringCommercial scale-up

Where you helpClinical operationsRegulatory affairsCMC and manufacturingQuality systemsMedical affairs

Approach preferences not yet specified

Company room Source

MoveFundingObserved8 months ago

Lyte

Undisclosed · USA · Other

What happened

Raised $107M.

The company said the funding supports build the perception foundation for autonomous machines.

Likely next InferredAggressive multi-front expansionSenior executive hiringOperational scale

Where you helpCommercial leadershipOperations hiringGo-to-market partnershipsFinance and compliance

Approach preferences not yet specified

Company room Source

MoveFundingObserved8 months ago

Rakuten Medical

Series F · San Diego, USA · Biotech & Pharma

What happened

Raised $100M in Series F funding.

The announcement did not set out what the funding supports.

Likely next InferredProduct launches and new tiersProduct leadership hiringCommercial team build-out

Where you helpScientific hiringLicensing and BD partnershipsProduct leadershipDesign partnersSpecialist engineering

Approach preferences not yet specified

Company room Source

MoveFundingObserved8 months ago

Swap

Series C · NYC, USA · Enterprise Software

What happened

Raised $100M in Series C funding, led by DST Global and ICONIQ.

The company said the funding supports continue to expand operations and its business reach, as well as to invest in digital payments and in monetizing transactions.

Likely next InferredNew market entryFirst local hires in the new marketLocal entity and legal setup

Where you helpCloud infrastructureChannel partnershipsMarket-entry advisersLocal employment infrastructureIn-market partnerships

Approach preferences not yet specified

Company room Source

MoveFundingObserved8 months ago

Cambium

Series B · El Segundo, USA · Defence, Space & Aerospace

What happened

Raised $100M in Series B funding, led by 8VC.

The company said the funding supports accelerate both its product pipeline and materials manufacturing in the U.S.

Likely next InferredProduct launches and new tiersProduct leadership hiringResearch programme expansion

Where you helpCertification and airworthinessManufacturing scale-upProduct leadershipDesign partnersSpecialist engineering

Approach preferences not yet specified

Company room Source

MoveFundingObserved8 months ago

Pomelo Care

Series C · NYC-based developer of evidence, USA · Healthcare & Medtech

What happened

Raised $92M in Series C funding.

The announcement did not set out what the funding supports.

Likely next InferredAccelerated hiring across functionsMulti-market operationsExecutive appointments

Where you helpClinical evidenceRegulatory affairsReimbursement and market accessHospital procurement experienceQuality systems

Approach preferences not yet specified

Company room Source

MoveFundingObserved8 months ago

Apella

Series B · San Francisco, USA · Healthcare & Medtech

What happened

Raised $80M in Series B funding.

The announcement did not set out what the funding supports.

Likely next InferredAccelerated hiring across functionsCommercial scale-upNew market preparation

Where you helpClinical evidenceRegulatory affairsReimbursement and market accessHospital procurement experienceQuality systems

Approach preferences not yet specified

Company room Source

MoveFundingObserved8 months ago

Corsera Health

Series A · Boston, USA · Biotech & Pharma

What happened

Raised $80M in Series A funding.

The announcement did not set out what the funding supports.

Likely next InferredResearch programme expansionScientific team growthAccelerated hiring across functions

Where you helpClinical operationsScientific hiringScientific advisersResearch operationsSpecialist suppliers

Approach preferences not yet specified

Company room Source

MoveFundingObserved8 months ago

Mediar Therapeutics

Series B · Boston, USA · Biotech & Pharma

What happened

Raised $76M in Series B funding, led by Amplitude Ventures and ICG.

The company said the funding supports further advance its wholly owned assets, including MTX-474, an antagonist of EphrinB2, being studied in a Phase 2a study in patients with systemic sclerosis (SSc), and MTX-439, a SMOC2 antagonist, proceeding to Phase 1 studies for the treatment of chronic kidney disease (CKD) associated fibrosis.

Likely next InferredResearch programme expansionScientific team growthAccelerated hiring across functions

Where you helpClinical operationsScientific hiringScientific advisersResearch operationsSpecialist suppliers

Approach preferences not yet specified

Company room Source

MoveFundingObserved8 months ago

Spiro Medical

Series A · Irvine, USA · Healthcare & Medtech

What happened

Raised $67M in Series A funding.

The announcement did not set out what the funding supports.

Likely next InferredAccelerated hiring across functionsRepeatable go-to-market buildFirst senior commercial hires

Where you helpClinical evidenceRegulatory affairsReimbursement and market accessHospital procurement experienceQuality systems

Approach preferences not yet specified

Company room Source

MoveFundingObserved8 months ago

Valinor Enterprises

Series A · Washington, USA · Defence, Space & Aerospace

What happened

Raised $54M in Series A funding.

The announcement did not set out what the funding supports.

Likely next InferredAccelerated hiring across functionsRepeatable go-to-market buildFirst senior commercial hires

Where you helpCertification and airworthinessGovernment relationsSecurity clearance hiringManufacturing scale-upSupply chain

Approach preferences not yet specified

Company room Source

MoveFundingObserved8 months ago

Poplar Therapeutics

Series A · Boston, USA · Biotech & Pharma

What happened

Raised $50M in Series A funding.

The announcement did not set out what the funding supports.

Likely next InferredResearch programme expansionScientific team growthAccelerated hiring across functions

Where you helpClinical operationsScientific hiringScientific advisersResearch operationsSpecialist suppliers

Approach preferences not yet specified

Company room Source

MoveFundingObserved8 months ago

Vizgen

Undisclosed · Waltham, USA · Other

What happened

Raised $48M.

The announcement did not set out what the funding supports.

Likely next InferredAccelerated hiring across functionsOperational scaleMarket consolidation

Where you helpCommercial leadershipOperations hiringGo-to-market partnershipsFinance and compliance

Approach preferences not yet specified

Company room Source

MoveFundingObserved8 months ago

GSME

Series B · San Jose, USA · Semiconductors & Hardware

What happened

Raised $35M in Series B funding, led by Maverick Silicon.

The company said the funding supports accelerate R&D, expand its platform development, and support strategic acquisitions and hiring.

Likely next InferredTeam growth across core functionsSenior leadership appointmentsNew market entry

Where you helpHardware engineeringIndustrial partnershipsExecutive searchTalent partnersEmployer infrastructure

Approach preferences not yet specified

Company room Source

MoveFundingObserved8 months ago

Protege

Series A · NYC, USA · AI & Data Infrastructure

What happened

Raised $30M in Series A funding.

The announcement did not set out what the funding supports.

Likely next InferredProduct launches and new tiersProduct leadership hiringAccelerated hiring across functions

Where you helpData partnershipsProduct leadershipDesign partnersSpecialist engineeringInfrastructure and compute

Approach preferences not yet specified

Company room Source

MoveFundingObserved8 months ago

Enable Injections

Series C · Cincinnati, USA · Healthcare & Medtech

What happened

Raised $30M in Series C funding, led by Magnetar Capital.

The company said the funding supports consolidate its supply chain capabilities, and drive commercial growth.

Likely next InferredCommercial team build-outRevenue leadership appointmentsManufacturing capacity expansion

Where you helpQuality systemsClinical hiringProvider partnershipsRevenue leadershipChannel partners

Approach preferences not yet specified

Company room Source

MoveFundingObserved8 months ago

Blackbird.AI

Undisclosed · NYC, USA · AI & Data Infrastructure

What happened

Raised $28M.

The announcement did not set out what the funding supports.

Likely next InferredAccelerated hiring across functionsOperational scaleMarket consolidation

Where you helpInfrastructure and computeAI governanceEnterprise salesSecurity reviewModel evaluation

Approach preferences not yet specified

Company room Source

MoveFundingObserved8 months ago

Flywheel

Undisclosed · Minneapolis, USA · Healthcare & Medtech

What happened

Raised $25M.

The announcement did not set out what the funding supports.

Likely next InferredProduct launches and new tiersProduct leadership hiringAccelerated hiring across functions

Where you helpProvider partnershipsProduct leadershipDesign partnersSpecialist engineeringClinical evidence

Approach preferences not yet specified

Company room Source

MoveFundingObserved8 months ago

Enodia Therapeutics

Seed · Paris, France · Biotech & Pharma

What happened

Raised €21M in Seed funding, led by Elaia.

The company said the funding supports the advancement of its small-molecule approach to modulating the SEC61 translocon, with machine learning enabling greater selectivity in targeted protein degradation than previous approaches.

Likely next InferredFounding team growthFirst commercial motion

Where you helpClinical operationsRegulatory affairsCMC and manufacturingQuality systemsMedical affairs

Approach preferences not yet specified

Company room Source

MoveFundingObserved8 months ago

Qualinx

Series B · Delft, Netherlands · Semiconductors & Hardware

What happened

Raised €20M in Series B funding, led by Invest‑NL.

The company said the funding supports accelerate growth to scale mass production of its market-ready QLX3Gx Series GNSS chip and fulfill demand from global OEMs across consumer electronics, including wearables, pet trackers, IoT, drones and UAVs, vehicle and asset tracking, telecommunications, satellites and more.

Likely next InferredProduct launches and new tiersProduct leadership hiringManufacturing capacity expansion

Where you helpCertificationHardware engineeringIndustrial partnershipsProduct leadershipDesign partners

Approach preferences not yet specified

Company room Source

MoveFundingObserved8 months ago

I-care

Undisclosed · Mons, Belgium · Healthcare & Medtech

What happened

Raised €20M, led by Fabrice Brion.

The company said the funding supports accelerate its growth in order to increase its market share, with plans to launch an initial public offering (postponed last spring).

Likely next InferredProduct launches and new tiersProduct leadership hiringOperational scale

Where you helpProvider partnershipsProduct leadershipDesign partnersSpecialist engineeringClinical evidence

Approach preferences not yet specified

Company room Source

MoveFundingObserved8 months ago

Biller Genie

Series B · Orlando, USA · Robotics & Manufacturing

What happened

Raised $22M in Series B funding.

The announcement did not set out what the funding supports.

Likely next InferredProduct launches and new tiersProduct leadership hiringPlatform and infrastructure scaling

Where you helpEngineering hiringDistribution partnersIndustrial partnershipsProduct leadershipDesign partners

Approach preferences not yet specified

Company room Source

MoveFundingObserved8 months ago

Canopy

Series B · San Francisco, USA · Healthcare & Medtech

What happened

Raised $22M in Series B funding.

The announcement did not set out what the funding supports.

Likely next InferredProduct launches and new tiersProduct leadership hiringCommercial scale-up

Where you helpProvider partnershipsProduct leadershipDesign partnersSpecialist engineeringClinical evidence

Approach preferences not yet specified

Company room Source

MoveFundingObserved8 months ago

Luxury Presence

Series C · Austin, USA · Fintech & Insurance

What happened

Raised $22M in Series C funding.

The announcement did not set out what the funding supports.

Likely next InferredProduct launches and new tiersProduct leadership hiringMulti-market operations

Where you helpBanking partnershipsProduct leadershipDesign partnersSpecialist engineeringCompliance and licensing

Approach preferences not yet specified

Company room Source

MoveFundingObserved8 months ago

Luminate

Series A · Galway, Ireland · Healthcare & Medtech

What happened

Raised $21M in Series A funding, led by ARTIS Ventures and Lachy Groom.

The company said the funding supports launch access to home cancer care at 40 partner oncology clinics before launching its new patient-led home infusion technology in mid-2026.

Likely next InferredProduct launches and new tiersProduct leadership hiringCommercial and distribution partnerships

Where you helpProvider partnershipsProduct leadershipDesign partnersSpecialist engineeringPartnership leadership

Approach preferences not yet specified

Company room Source

MoveFundingObserved8 months ago

Tucuvi

Series A · Madrid, Spain · Healthcare & Medtech

What happened

Raised $20M in Series A funding, led by Cathay Innovation and Kibo Ventures.

The company said the funding supports accelerate international expansion, particularly in the United Kingdom and United States, and enhance its AI technology to manage more complex clinical use cases.

Likely next InferredGlobal market entryUK market entryUS market entry

Where you helpProvider partnershipsMarket-entry advisersLocal employment infrastructureIn-market partnershipsProduct leadership

Approach preferences not yet specified

Company room Source

MoveFundingObserved8 months ago

Prudentia Sciences

Series A · Cambridge, USA · AI & Data Infrastructure

What happened

Raised $20M in Series A funding.

The announcement did not set out what the funding supports.

Likely next InferredRepeatable go-to-market buildFirst senior commercial hires

Where you helpInfrastructure and computeAI governanceEnterprise salesSecurity reviewModel evaluation

Approach preferences not yet specified

Company room Source

MoveFundingObserved8 months ago

Array Labs

Series A · Palo Alto, USA · Defence, Space & Aerospace

What happened

Raised $20M in Series A funding, led by Catapult Ventures.

The announcement did not set out what the funding supports.

Likely next InferredOperational scaleMarket consolidation

Where you helpCertification and airworthinessGovernment relationsSecurity clearance hiringManufacturing scale-upSupply chain

Approach preferences not yet specified

Company room Source

The Daily Brief

This page, in your inbox.

Every disclosed US, UK and European round of $5M or more, with what each company said the money supports, the morning it is observed. One email, only on days something happened, unsubscribe with one click.